David Turkaly
Stock Analyst at Citizens
(2.18)
# 2,812
Out of 5,163 analysts
148
Total ratings
38.97%
Success rate
-3.96%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Maintains: Market Outperform | $78 → $85 | $79.49 | +6.93% | 11 | Feb 27, 2026 | |
| AXGN Axogen | Maintains: Market Outperform | $34 → $42 | $32.34 | +29.87% | 9 | Feb 24, 2026 | |
| MDXG MiMedx Group | Initiates: Market Outperform | $10 | $4.38 | +128.31% | 1 | Feb 23, 2026 | |
| SYK Stryker | Upgrades: Market Outperform | $440 | $336.77 | +30.65% | 4 | Dec 19, 2025 | |
| TELA TELA Bio | Maintains: Market Outperform | $7 → $5 | $0.74 | +575.86% | 7 | Nov 14, 2025 | |
| APYX Apyx Medical | Upgrades: Market Outperform | $8 | $3.63 | +120.39% | 6 | Nov 12, 2025 | |
| KIDS OrthoPediatrics | Maintains: Market Outperform | $35 → $25 | $17.31 | +44.43% | 12 | Oct 10, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $11.70 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $84.77 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $59.92 | +66.89% | 12 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $265 → $280 | $214.57 | +30.49% | 18 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $35 → $25 | $9.24 | +170.56% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $62 → $55 | $22.99 | +139.23% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $140 → $125 | $93.20 | +34.12% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $400 → $500 | $441.78 | +13.18% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $107.32 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $13.05 | +145.21% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $4.56 | +250.88% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $1.30 | +131.66% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $8.40 | -40.48% | 1 | Oct 6, 2017 |
Lantheus Holdings
Feb 27, 2026
Maintains: Market Outperform
Price Target: $78 → $85
Current: $79.49
Upside: +6.93%
Axogen
Feb 24, 2026
Maintains: Market Outperform
Price Target: $34 → $42
Current: $32.34
Upside: +29.87%
MiMedx Group
Feb 23, 2026
Initiates: Market Outperform
Price Target: $10
Current: $4.38
Upside: +128.31%
Stryker
Dec 19, 2025
Upgrades: Market Outperform
Price Target: $440
Current: $336.77
Upside: +30.65%
TELA Bio
Nov 14, 2025
Maintains: Market Outperform
Price Target: $7 → $5
Current: $0.74
Upside: +575.86%
Apyx Medical
Nov 12, 2025
Upgrades: Market Outperform
Price Target: $8
Current: $3.63
Upside: +120.39%
OrthoPediatrics
Oct 10, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $17.31
Upside: +44.43%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $11.70
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $84.77
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $59.92
Upside: +66.89%
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $214.57
Upside: +30.49%
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $9.24
Upside: +170.56%
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $22.99
Upside: +139.23%
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $93.20
Upside: +34.12%
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $441.78
Upside: +13.18%
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $107.32
Upside: -
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $13.05
Upside: +145.21%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $4.56
Upside: +250.88%
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $1.30
Upside: +131.66%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $8.40
Upside: -40.48%